Potomac Health News: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Potomac Health News.

Press releases published on October 6, 2026

2 hours ago

Quoin Pharmaceuticals Announces Acceptance of QRX003 Paper in Dermatology and Therapy

Indeterminate GlobeNewswire

2 hours ago

First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

Indeterminate GlobeNewswire

3 hours ago

MediciNova to Participate in the Maxim Growth Summit

Indeterminate GlobeNewswire

4 hours ago

PathMaker Neurosystems Announces Publication of First-Ever Study Showing Non-Invasive Clearance of Toxic TDP-43 Protein Aggregates in Preclinical ALS Study

Indeterminate GlobeNewswire

5 hours ago

Smith+Nephew’s revolutionary CARTIHEAL™ AGILI-C™ Cartilage Repair Implant launches in Europe; to be featured at ICRS Summit in Portugal

Indeterminate GlobeNewswire

5 hours ago

Smith+Nephew lancia in Europa CARTIHEAL™ AGILI-C™, l’innovativo impianto per la riparazione della cartilagine, che sarà presentato all’ICRS Summit in Portogallo.

Indeterminate GlobeNewswire

5 hours ago

Smith+Nephew lanza en Europa el innovador implante de reparación de cartílago CARTIHEAL™ AGILI-C™, que será protagonista en el Congreso ICRS de Portugal

Indeterminate GlobeNewswire

5 hours ago

Resolution Therapeutics to present interim Phase I/II EMERALD study data on RTX001 as a late-breaker at AASLD 2026

Indeterminate GlobeNewswire

6 hours ago

RQ Bio Appoints Gavin Koh as Chief Medical Officer and Strengthens Leadership to Advance RQB01

Indeterminate GlobeNewswire

6 hours ago

Angelini Ventures and EIB Co-lead $58 Million Series A Financing in Rouge Therapeutics to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

6 hours ago

Rewind Therapeutics Secures Additional Financing to Advance Oral GPR17 Remyelination Program

Indeterminate GlobeNewswire

6 hours ago

RougeTx Launches with $58 Million Series A Financing to Advance First-in-Class Treatment for Hereditary Hemorrhagic Telangiectasia

Indeterminate GlobeNewswire

6 hours ago

One04 Therapeutics to present late-breaking interim Phase 1 results for CPV-104 in C3 glomerulopathy at ASN Kidney Week followed by Virtual KOL Event

Indeterminate GlobeNewswire

7 hours ago

Press Release : Availability of the aide-mémoire for Q3 2026 results

Indeterminate GlobeNewswire

7 hours ago

Communiqué de presse : Mise en ligne du document «Q3 2026 aide-mémoire »

Indeterminate GlobeNewswire

7 hours ago

Nox Peptides Announces Expanded Research Focus on BPC-157 as Canadian Peptide Research Supply Demand Grows

Indeterminate GlobeNewswire

8 hours ago

Peptides Canada Operated by Growth Guys Announces Launch of Domestic Research Peptide Supply Platform

Indeterminate GlobeNewswire

9 hours ago

Warm Breezes and Light Clouds, Time to Recharge: Huangshan Is Emerging as an Oriental Wellness Destination for Young Korean Travelers

Indeterminate GlobeNewswire

9 hours ago

바람은 따뜻하고 구름은 가볍게—중국 황산, 한국 MZ세대의 동양미학 힐링 여행지로 주목

Indeterminate GlobeNewswire

13 hours ago

Spyre Therapeutics Announces Pricing of $350.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire